Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC BioMed Corporate Update

C.THC

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 1, 2015) - THC BioMed Intl Ltd. (CSE:THC)(FRANKFURT:TFHC)(OTC PINK:THCBF) ("THC") is pleased to provide its shareholders with a Corporate update. The company would like to advise that Health Canada inspectors have conducted a second pre-licensing inspection on August 20, 2015 at its THC BioMed Ltd facility located in Kelowna BC. Upon completion of the inspection there were no further deficiencies indicated.

This brings us a step closer to fulfilling the milestone of being approved as a Licensed Producer. While THC BioMed remains optimistic that its MMPR application will be approved and that it will be granted an MMPR license, there is no assurance that this will happen. THC will continue to work diligently with regulators through the final stages of the licensing process. 

THC's vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Please visit our website for a more detailed description of our business and services available.
www.thcbiomed.com

Forward-Looking Information:

This press release contains certain "forward-looking information" within the meaning of applicable securities law. The forward looking statements include that (i) As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THC's Listing Statement, Financial Statements and its Management's Discussion and Analysis on www.sedar.com.

THC Biomed Intl Ltd.
John Miller
President and CEO
T: 1844-842-6337 (THC-MEDS)
E: info@thcbiomed.com
www.thcbiomed.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today